Shekeyla Young
Physician Assistant · Newkirk, OKNPI 1013586445
Payments from drug & device makers
Across 149 payments — averaging $24.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$722
- Alkermes, Inc.$715
- AbbVie$628
- Corium, LLC$311
- Teva Pharmaceuticals USA, Inc.$250
- Lundbeck LLC$248
- plus $742 from 8 others
What the payments were for
- Food & beverage$3,615100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $722 |
| Alkermes, Inc. | 15 | $715 |
| AbbVie | 37 | $628 |
| Corium, LLC | 8 | $311 |
| Teva Pharmaceuticals USA, Inc. | 8 | $250 |
| Lundbeck LLC | 17 | $248 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $237 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $195 |
| Johnson & Johnson | 10 | $171 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $47 |
| Ironshore Pharmaceuticals Inc. | 2 | $33 |
| Alfasigma USA, Inc. | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Livanova USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,615 in reported general payments places this provider in the 85th percentile of 1,491 physician assistant providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 11 | $18,379 |
| Aripiprazole | 21 | $4,434 |
| Trazodone Hcl | 43 | $1,166 |
| Duloxetine Hcl | 46 | $694 |
| Fluoxetine Hcl | 30 | $483 |
| Bupropion XlBupropion Hcl | 20 | $231 |
| Olanzapine | 26 | $206 |
| Buspirone Hcl | 22 | $172 |
| Lamotrigine | 20 | $162 |
| Quetiapine Fumarate | 18 | $134 |
| Benztropine Mesylate | 15 | $120 |
| Clonazepam | 16 | $96 |
| Citalopram HbrCitalopram Hydrobromide | 20 | $56 |
| Escitalopram Oxalate | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $195 | $18,37911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,491 physician assistant providers in Oklahoma.
Other physician assistant in Newkirk
- Eric CampbellEdmond$246K
- Katherine DemersEl Reno$146K
- Jennifer SmithOklahoma City$134K
- Christy NiehuesMustang$28K
- Matthew PattonTulsa$24K
- Sarah HawkOklahoma City$23K
- Gavin ChristieEdmond$19K
- Michelle GreenTulsa$18K
- Muge ParkTulsa$17K
- Rose RamirezTulsa$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.